Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1S23
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $138,795
Award facts
- Contract value 100% obligated
- $138,795.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $138,795.26 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on December 30, 2025, with a completion date of December 31, 2025. The contract employs firm fixed price terms and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026.
Dupixent (dupilumab) is a biologic medication commonly prescribed for severe asthma, eczema, and other inflammatory conditions. This delivery order reflects the Defense Health Agency's ongoing pharmaceutical supply requirements through AmerisourceBergen Drug Corp's established prime vendor relationship with DLA. The contract is classified as a child award under the broader IDC vehicle, enabling flexible fulfillment of military healthcare pharmaceutical needs. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts demonstrates its capability to deliver specialized and brand-name pharmaceuticals competitively to support Department of Defense health operations.
Quick answers
Who was awarded contract SPE2DR26F1S23?
SPE2DR26F1S23 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F1S23 worth?
The government has obligated $138,795 on SPE2DR26F1S23.
Is contract SPE2DR26F1S23 an order under another contract?
Yes. SPE2DR26F1S23 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1S23 competed?
The extent of competition for SPE2DR26F1S23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award